ES2136059T3 - Deteccion de una secuencia de acidos nucleicos o de un cambio en la misma. - Google Patents

Deteccion de una secuencia de acidos nucleicos o de un cambio en la misma.

Info

Publication number
ES2136059T3
ES2136059T3 ES90903297T ES90903297T ES2136059T3 ES 2136059 T3 ES2136059 T3 ES 2136059T3 ES 90903297 T ES90903297 T ES 90903297T ES 90903297 T ES90903297 T ES 90903297T ES 2136059 T3 ES2136059 T3 ES 2136059T3
Authority
ES
Spain
Prior art keywords
primer
polynucleotide sequence
fraction
extended
extended primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90903297T
Other languages
English (en)
Other versions
ES2136059T5 (es
Inventor
James Langham Dale
Peter Timms
Terence Patrick Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geneco Pty Ltd
Original Assignee
Geneco Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3773706&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2136059(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geneco Pty Ltd filed Critical Geneco Pty Ltd
Publication of ES2136059T3 publication Critical patent/ES2136059T3/es
Application granted granted Critical
Publication of ES2136059T5 publication Critical patent/ES2136059T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Abstract

SE DESCRIBE UN METODO PARA DETECTAR UNA SECUENCIA ESPECIFICA DE POLINUCLEOTIDO EN UNA MATERIA. EL METODO INCLUYE LA EXPOSICION DE DICHA MATERIA A UN OLIGONUCLEOTIDO PRIMARIO, CON UNA SECUENCIA COMPLEMENTARIA, A PARTE DE LA SECUENCIA ESPECIFICA DE POLINUCLEOTIDO MENCIONADA EN LA QUE ESTE ELEMENTO PRIMARIO SE ADHIERE A PARTE DE LA SECUENCIA DE POLINUCLEOTIDO MENCIONADA CUANDO ESTA PRESENTE EN DICHA MATERIA. EL ELEMENTO PRIMARIO UNIDO A LA SECUENCIA DE POLINUCLEOTIDO SE EXTIENDE EN DONDE CUALQUIER ELEMENTO PRIMARIO INCLUYE UN ELEMENTO DETECTABLE Y/O UN ELEMENTO DE SEPARACION. CUALQUIER ELEMENTO PRIMARIO EXTENDIDO SE SEPARA DESPUES EN UNA FRACCION EN DONDE DICHA FRACCION NO TIENE ELEMENTO DETECTABLE NO INCLUIDO EN DICHO ELEMENTO PRIMARIO EXTENDIDO. SE DETERMINA ENTONCES SI CUALQUIER ELEMENTO PRIMARIO EXTENDIDO ESTA PRESENTE EN DICHA FRACCION PROBANDO DICHA FRACCION PARA EL ELEMENTO PRIMARIO EXTENDIDO EN DONDE LA PRESENCIA DE DICHO ELEMENTO PRIMARIO EXTENDIDO ES INDICATIVO DE LA PRESENCIA DE LASECUENCIA ESPECIFICA DE POLINUCLEOTIDO EN DICHA MATERIA Y LA AUSENCIA DE DICHO ELEMENTO PRIMARIO EXTENDIDO EN DICHA FRACCION ES INDICATIVA DE LA AUSENCIA DE LA SECUENCIA ESPECIFICA DE POLINUCLEOTIDO EN DICHA MATERIA.
ES90903297T 1989-02-13 1990-02-13 Deteccion de una secuencia de acidos nucleicos o de un cambio en la misma. Expired - Lifetime ES2136059T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ270389 1989-02-13
AU270389 1989-02-13

Publications (2)

Publication Number Publication Date
ES2136059T3 true ES2136059T3 (es) 1999-11-16
ES2136059T5 ES2136059T5 (es) 2005-02-16

Family

ID=3773706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90903297T Expired - Lifetime ES2136059T5 (es) 1989-02-13 1990-02-13 Deteccion de una secuencia de acidos nucleicos o de un cambio en la misma.

Country Status (11)

Country Link
EP (1) EP0457824B2 (es)
JP (1) JP3021036B2 (es)
AT (1) ATE181576T1 (es)
AU (1) AU656514B2 (es)
CA (1) CA2044591C (es)
DE (1) DE69033179T3 (es)
DK (1) DK0457824T4 (es)
ES (1) ES2136059T5 (es)
IE (1) IE66572B1 (es)
SG (1) SG50434A1 (es)
WO (1) WO1990009455A1 (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
JPH03123500A (ja) * 1989-10-06 1991-05-27 Canon Inc 核酸の分別方法
US6013431A (en) 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
IL97222A (en) * 1990-02-16 1995-08-31 Orion Yhtymae Oy Method and Responder for Determining Special Changes to Nucleotide
US5126239A (en) * 1990-03-14 1992-06-30 E. I. Du Pont De Nemours And Company Process for detecting polymorphisms on the basis of nucleotide differences
IE66125B1 (en) * 1991-01-31 1995-12-13 Zeneca Ltd Detection method for variant nucleotides
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5294534A (en) * 1991-08-13 1994-03-15 Miles, Inc. Amplification method for polynucleotide assays
ATE192503T1 (de) * 1991-12-24 2000-05-15 Tepnel Medical Ltd Manipulation von nukleinsäuresequenzen
GB9127415D0 (en) * 1991-12-24 1992-02-19 Swordfish Int Ltd Solid support bound detection and diagnostic system
EP1302547A3 (en) * 1992-06-17 2003-11-12 City Of Hope A method of detecting and discriminating between nucleic acid sequences
WO1993025563A1 (en) * 1992-06-17 1993-12-23 City Of Hope A method of detecting and discriminating between nucleic acid sequences
US5981176A (en) * 1992-06-17 1999-11-09 City Of Hope Method of detecting and discriminating between nucleic acid sequences
SE9201929D0 (sv) * 1992-06-23 1992-06-23 Pharmacia Lkb Biotech Method and system for molecular-biological diagnostics
CA2139433A1 (en) * 1992-07-02 1994-01-20 Nurit Eyal Methods of single nucleotide primer extension to detect specific alleles and kits therefor
US5710028A (en) * 1992-07-02 1998-01-20 Eyal; Nurit Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor
US6153379A (en) * 1993-06-22 2000-11-28 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
US7001722B1 (en) 1993-06-22 2006-02-21 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
AU8132194A (en) * 1993-11-03 1995-05-23 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
US6027883A (en) * 1994-03-30 2000-02-22 Mitokor Optimal procedure for isolation of mutant mitochondrial alleles
US5976798A (en) * 1994-03-30 1999-11-02 Mitokor Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid
CN1152946A (zh) * 1994-05-28 1997-06-25 特普尼尔医学有限公司 生产核酸的拷贝
US5641658A (en) * 1994-08-03 1997-06-24 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid with two primers bound to a single solid support
US6090592A (en) * 1994-08-03 2000-07-18 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid on supports
US6060288A (en) * 1994-08-03 2000-05-09 Mosaic Technologies Method for performing amplification of nucleic acid on supports
AU5296496A (en) * 1995-03-24 1996-10-16 Mitokor Mutation detection by differential primer extension of mutant and wildtype target sequences
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
GB9517914D0 (en) * 1995-09-02 1995-11-01 Tepnel Medical Ltd Identification of bases in nucleic acid sequences
WO1997010359A1 (fr) * 1995-09-13 1997-03-20 Wakunaga Seiyaku Kabushiki Kaisha Procede de concentration d'acide nucleique variant et materiel de test de concentration d'acide nucleique de mise en application du procede
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
EP3034626A1 (en) 1997-04-01 2016-06-22 Illumina Cambridge Limited Method of nucleic acid sequencing
US6566101B1 (en) 1997-06-16 2003-05-20 Anthony P. Shuber Primer extension methods for detecting nucleic acids
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6194160B1 (en) * 1998-03-19 2001-02-27 Immunetics, Inc. Systems and methods for rapid blot screening
US6818404B2 (en) 1997-10-23 2004-11-16 Exact Sciences Corporation Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples
WO2000011215A2 (en) * 1998-08-14 2000-03-02 Exact Laboratories, Inc. Method for diagnostic screening
US6203990B1 (en) 1998-11-06 2001-03-20 Mitokor Method and system for pattern analysis, such as for analyzing oligonucleotide primer extension assay products
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
DE60038109T2 (de) * 1999-04-09 2008-11-27 Keygene N.V. Verfahren zur Analyse von AFLP Reaktionsmischungen unter Verwendung von Primer Verlängerungstechniken
US6573047B1 (en) 1999-04-13 2003-06-03 Dna Sciences, Inc. Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation
EP1171637A2 (en) * 1999-04-27 2002-01-16 The University Of Chicago Nucleotide extension on a microarray of gel-immobilized primers
WO2001021838A2 (en) * 1999-09-22 2001-03-29 Motorola Inc. Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms
JP2003517309A (ja) 1999-12-02 2003-05-27 ディーエヌエー サイエンシーズ インコーポレーテッド 単一ヌクレオチドの変異及びジェノタイピングの決定方法
US20020018999A1 (en) * 2000-02-24 2002-02-14 Jan Henriksson Methods for characterizing polymorphisms
US6376191B1 (en) * 2000-03-22 2002-04-23 Mergen, Ltd. Microarray-based analysis of polynucleotide sequence variations
US6355433B1 (en) 2000-06-02 2002-03-12 Dna Sciences, Inc. Determination of nucleotide sequence variations through limited primer extension
JP2004520812A (ja) * 2000-08-30 2004-07-15 ハプロゲン・エルエルシー 対立遺伝子を決定するための方法
AR031640A1 (es) 2000-12-08 2003-09-24 Applied Research Systems Amplificacion isotermica de acidos nucleicos en un soporte solido
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
AU2002358110A1 (en) 2001-12-10 2003-07-09 Novartis Ag Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
EP1571210A4 (en) * 2002-12-10 2006-08-16 Olympus Corp METHOD FOR ANALYZING THE VARIATION OF NUCLEIC ACID MUTATION AND METHOD FOR GENE EXPRESSION ANALYSIS
DE602004030271D1 (de) 2003-09-12 2011-01-05 Univ Cincinnati Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren
ATE469245T1 (de) 2004-09-14 2010-06-15 Univ Colorado Auf genetischem targeting basierendes verfahren zur behandlung mit bucindolol
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
WO2008093098A2 (en) 2007-02-02 2008-08-07 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple nucleotide templates
AU2008260029B2 (en) 2007-05-31 2015-02-12 Yale University A genetic lesion associated with cancer
EP2149612A1 (en) 2008-07-29 2010-02-03 Merck Serono SA Genetic markers of response to efalizumab
WO2010038042A1 (en) 2008-10-02 2010-04-08 Illumina Cambridge Ltd. Nucleic acid sample enrichment for sequencing applications
WO2010077832A1 (en) 2008-12-15 2010-07-08 Wisconsin Alumni Research Foundation Methods and compositions for testing and breeding cattle for improved fertility and embryonic survival
CA2751287A1 (en) 2009-02-06 2010-09-10 Yale University A snp marker of breast and ovarian cancer risk
EP2446056A2 (en) 2009-06-25 2012-05-02 Yale University Single nucleotide polymorphisms in brca1 and cancer risk
US8182994B2 (en) 2009-09-15 2012-05-22 Illumina Cambridge Limited Centroid markers for image analysis of high denisty clusters in complex polynucleotide sequencing
US20140024590A1 (en) 2011-02-18 2014-01-23 Yale University KRAS-Variant And Endometriosis
US20140065615A1 (en) 2011-03-21 2014-03-06 Yale University The KRAS Variant and Tumor Biology
WO2013045505A1 (en) 2011-09-28 2013-04-04 Novartis Ag Biomarkers for raas combination therapy
US10221456B2 (en) 2012-08-06 2019-03-05 Merck Patent Gmbh Genetic markers for predicting responsiveness to FPG-18 compound
EP2912194B1 (en) 2012-10-26 2019-05-08 Memorial Sloan-Kettering Cancer Center Androgen receptor variants and methods for making and using
EP3008211A4 (en) 2013-06-11 2016-12-21 Courtagen Life Sciences Inc METHOD AND KITS FOR TREATMENT AND CLASSIFICATION OF PERSONS WITHOUT THE RISK OF AN EXISTING OR EXISTING TRAP1 FUNCTIONAL CHANGE
KR20180033235A (ko) 2015-07-23 2018-04-02 머크 샤프 앤드 돔 코포레이션 Crth2 수용체 길항제에 대한 반응과 연관된 유전자 마커
JP2019515035A (ja) 2016-04-27 2019-06-06 ミラ ディーエックス， インコーポレイテッド Ｋｒａｓバリアントがん患者の免疫ベースの処置
WO2018111662A1 (en) 2016-12-14 2018-06-21 Merck Sharp & Dohme Corp. Human genetic markers associated with response to treatments that target clostridium difficile toxin b

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307189A (en) * 1980-03-21 1981-12-22 Malon Kit Method for the quantitative determination of terminal deoxynucleotidyl transferase in biological samples
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4868104A (en) * 1985-09-06 1989-09-19 Syntex (U.S.A.) Inc. Homogeneous assay for specific polynucleotides
US4851331A (en) * 1986-05-16 1989-07-25 Allied Corporation Method and kit for polynucleotide assay including primer-dependant DNA polymerase
AU622104B2 (en) * 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
CA1317535C (en) 1987-06-30 1993-05-11 Nanibhushan Dattagupta Assay of sequences using amplified genes
DE68908054T2 (de) * 1988-01-21 1994-03-10 Genentech Inc Verstärkung und nachweis von nukleinsäuresequenzen.
WO1989010414A1 (en) † 1988-04-28 1989-11-02 Robert Bruce Wallace AMPLIFIED SEQUENCE POLYMORPHISMS (ASPs)
WO1990001069A1 (en) * 1988-07-20 1990-02-08 Segev Diagnostics, Inc. Process for amplifying and detecting nucleic acid sequences
GB8827160D0 (en) † 1988-11-21 1988-12-29 Apothekernes Lab Detection & quantitative determination of rna & dna

Also Published As

Publication number Publication date
EP0457824A1 (en) 1991-11-27
DK0457824T4 (da) 2004-10-11
EP0457824A4 (en) 1992-07-08
IE900501L (en) 1990-08-13
DE69033179T3 (de) 2005-01-27
ES2136059T5 (es) 2005-02-16
DE69033179D1 (de) 1999-07-29
AU5106990A (en) 1990-09-05
CA2044591C (en) 2002-08-13
DE69033179T2 (de) 2000-01-05
EP0457824B2 (en) 2004-06-09
DK0457824T3 (da) 2000-01-24
CA2044591A1 (en) 1990-08-14
AU656514B2 (en) 1995-02-09
JPH04503158A (ja) 1992-06-11
SG50434A1 (en) 1998-07-20
JP3021036B2 (ja) 2000-03-15
IE66572B1 (en) 1996-01-24
WO1990009455A1 (en) 1990-08-23
EP0457824B1 (en) 1999-06-23
ATE181576T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
ES2136059T3 (es) Deteccion de una secuencia de acidos nucleicos o de un cambio en la misma.
DE68908054T2 (de) Verstärkung und nachweis von nukleinsäuresequenzen.
ES2006377A6 (es) Un metodo de analisis de acidos nucleicos por hibridacion.
DE69227379D1 (de) Verfahren und Reagenzien zur Bestimmung von Bakterien in der zerebrospinalen Flüssigkeit
NO165975C (no) Todelt reagens for bruk ved detektering i en proeve av en analytt, et sett for detektering av en analytt samt anvendelse av reagensen.
MY103811A (en) Detection of chemicals by immunoassay
DE69718268D1 (de) Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse
GB2233450B (en) Detecting or quantifing multiple analytes with luminescent reagents
DE69623458D1 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
NZ306051A (en) Testing using electrochemiluminescence
DE69521104D1 (de) Spezifische Bindungstests und Reagenzien dafür
ATE15549T1 (de) Methode und reagenzsatz zur feststellung von schwangerschaft.
EP0402846A3 (en) Fluorescence polarization immunoassay for tetrahydrocannabinoids
WO1998014611A3 (en) Detection and identification of non-polio enteroviruses
ATE7542T1 (de) Verfahren und reagens zum nachweis von fibrinmonomer.
DE68908257T2 (de) Millonreagenz zum Nachweis von Krebs.
EP0848251A3 (en) Homogeneous on-line assays using capillary electrophoresis
FR2728687B1 (es)
DE3174170D1 (en) Cytoreceptor assay
DE3668067D1 (de) Reagens zur feststellung von antigen-antikoerper-reaktionen.
FR2693740B1 (fr) Procédé de détection tissulaire ou cellulaire mettant en Óoeuvre des réactifs chimiluminescents.
ATE120009T1 (de) Verfahren zur quantitativen bestimmung von serumproteinen in körperflüssigkeiten und mittel zur durchführung des verfahrens.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 457824

Country of ref document: ES